UK Defra ADCR decisions published


On 19 January 2026 Defra granted Decisions for the three initial applications (AFA059, AFA061 and AFA063) which we published as news on 3 February. 

The granted review period for these three applications is 12 years. The Decisions are available on Authorisation decisions: UK REACH - GOV.UK. 

The Defra Decision come with a series of conditions that users of chromates should be fulfilling and these measures will apply from the 19 August 2026.  

To support the sharing of these GB obligations the ADCR Service Team prepared Formal Communication Letters that were shared with the Authorisation Holders for disseminating to their downstream users. 

These ADCR formal Communication letters have now been added to ADCR Guidance and Support, the letters set out the Authorisation conditions and monitoring arrangements as well for existing stock and REACH Article 66 obligations. 

For the four review report applications AFA058, AFA060, AFA062 and AFA064, Defra is expecting to make their decisions later in March 2026. As these applications are all review reports the use can continue until Defra makes its decision. 

The ADCR Service Team will update guidance documents on the ADCR website to cover the obligations of the Defra ADCR Authorisation decisions. The guidance is intended for Downstream Users of soluble chromates in GB. ADCR will also hold a webinar later in spring 2026 (April/May) to present the UK decisions and conditions. 
Other news items:

19 November 2026
ECHA's Committee on Socio-economic Analysis (SEAC) adopted its final opinion on Cr(VI) restriction in their November meeting, and ECHA published news and extracts of action points today, 19 November 2026. SEAC concludes that the restriction options (RO1 and RO2) can be proportionate if the transitional period of 36 months for RO1, and longer than 36 months if RO2 are used. SEAC says that RO1 is having minor costs and very limited benefits and SEAC considers that RO2 is the option with the highest benefits that is still likely to be proportionate and practical. If a harmonised LV is preferred by the decision maker and distributional impacts are factored in by them, a uniform limit of 0.5 µg/m3 (in combination with ELVs of RO2) could also be an appropriate option. However, SEAC cannot come to a conclusion on whether a restriction is the most appropriate risk management option overall. ECHA has indicated that they will publish the opinion in the next few weeks. See ECHA news and extracts from the SEAC action points .
Show More